← Back to Search

Music Therapy for Alzheimer's Disease

N/A
Recruiting
Led By Joanne Loewy, DA, LCAT, MT-BC
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Alzheimer's disease or mild cognitive impairment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare the effects of music therapy experiences on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment.

Eligible Conditions
  • Alzheimer's Disease
  • Mild Cognitive Impairment

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with Alzheimer's disease or mild cognitive impairment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activities of Daily Living (ADCS-ADL)
Clinician's Global Impression of Change (ADCS-CGIC)
Mini Mental Status Exam (MMSE)
+1 more
Secondary outcome measures
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)
Zarit Burden Interview

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Home-based MT through Supervised, Supported Singing (H3S)Experimental Treatment1 Intervention
Treatment arm 1
Group II: H3S and IMTExperimental Treatment2 Interventions
Treatment arm 2 received both Home-based Supervised, Supported Singing (H3S) and Individualized Music Therapy (IMT)
Group III: Attention Control (AtCon)Placebo Group1 Intervention
Comparison condition with comparable attention

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
850 Previous Clinical Trials
535,734 Total Patients Enrolled
Joanne Loewy, DA, LCAT, MT-BCPrincipal InvestigatorMount Sinai Beth Israel
1 Previous Clinical Trials
178 Total Patients Enrolled
Mary Sano, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
1,221 Total Patients Enrolled

Media Library

Home-based MT through Supervised, Supported Singing (H3S) Clinical Trial Eligibility Overview. Trial Name: NCT04666077 — N/A
Alzheimer's Disease Research Study Groups: Home-based MT through Supervised, Supported Singing (H3S), H3S and IMT, Attention Control (AtCon)
Alzheimer's Disease Clinical Trial 2023: Home-based MT through Supervised, Supported Singing (H3S) Highlights & Side Effects. Trial Name: NCT04666077 — N/A
Home-based MT through Supervised, Supported Singing (H3S) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04666077 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings to participate in the trial at this time?

"Clinicaltrials.gov lists this trial as currently recruiting participants, with a posting date of July 25th 2019 and an edit on December 7th 2020."

Answered by AI

How many participants have enrolled in this research initiative?

"Affirmative. The information hosted on clinicaltrials.gov specifies that this medical experiment is presently bringing in patients; it was first posted on July 25th 2019 and its details were recently updated on December 7th 2020. One hundred participants are needed between two locations for the trial to be complete."

Answered by AI

Who else is applying?

What site did they apply to?
Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

What questions have other patients asked about this trial?

How long will screening last?
PatientReceived no prior treatments
~18 spots leftby Mar 2025